Global Breast Cancer Mammography Screening Market & Forecast
For more Information: http://www.renub.com/breast-cancer-screening-market-is-estimated-to-be-more-than-us-20-billion-by-2022-37-nd.php Breast Cancer Screening Market is estimated to cross the figure of US$ 20 Billion by 2022. Breast Cancer Screening means checking a woman’s breast for cancer before the symptoms and sign of the diseases. Breast cancer screening cannot prevent breast cancer, but it is helpful in finding breast cancer early when it is easier to be treated. Health care provider needs to inform all women irrespective of their patients about the best screening options for them. The three types of option available are Mammogram, MRI Screening and Ultrasound. According to The United State Preventive Services Task Force (USPSTF) report, women who are at the age of 50 to 74 years are at an average risk for breast cancer. Women who are of age 40 to 49 years should consult with their doctors about when to start and how often to get a mammogram.
For more Information: http://www.renub.com/breast-cancer-screening-market-is-estimated-to-be-more-than-us-20-billion-by-2022-37-nd.php
Breast Cancer Screening Market is estimated to cross the figure of US$ 20 Billion by 2022. Breast Cancer Screening means checking a woman’s breast for cancer before the symptoms and sign of the diseases. Breast cancer screening cannot prevent breast cancer, but it is helpful in finding breast cancer early when it is easier to be treated. Health care provider needs to inform all women irrespective of their patients about the best screening options for them. The three types of option available are Mammogram, MRI Screening and Ultrasound.
According to The United State Preventive Services Task Force (USPSTF) report, women who are at the age of 50 to 74 years are at an average risk for breast cancer. Women who are of age 40 to 49 years should consult with their doctors about when to start and how often to get a mammogram.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> is estimated to be more than US$ 20 Billion by 2022<br />
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> is estimated to be more<br />
than US$ 20 Billion by 2022<br />
Analyst View:<br />
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> is expected to be more than US$ 20 Billion by 2022. <strong>Breast</strong><br />
cancer is the 2nd most common cancer among the women in the world. Number of breast<br />
cancer cases in less developed regions is higher than developed regions.<br />
For More Information:<br />
http://www.renub.com/breast-cancer-screening-market-is-estimated-to-be-more-than-us-<br />
20-billion-by-2022-37-nd.php<br />
Access Full Research: http://www.renub.com/breast-cancer-screeningmammography-mri-and-ultrasound-market-and-forecast-worldwide-63-p.php<br />
Get 10% Free Customization in this Report<br />
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> is estimated to cross the figure of US$ 20 Billion by 2022.<br />
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> means checking a woman’s breast for cancer before the symptoms and<br />
sign of the diseases. <strong>Breast</strong> cancer screening cannot prevent breast cancer, but it is helpful in<br />
finding breast cancer early when it is easier to be treated. Health care provider needs to inform<br />
all women irrespective of their patients about the best screening options for them. The three<br />
types of option available are Mammogram, MRI <strong>Screening</strong> and Ultrasound.<br />
According to The United State Preventive Services Task Force (USPSTF) report, women who are<br />
at the age of 50 to 74 years are at an average risk for breast cancer. Women who are of age<br />
40 to 49 years should consult with their doctors about when to start and how often to get a<br />
mammogram.<br />
© Renub Research LLP Page 1 of 4
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> is estimated to be more than US$ 20 Billion by 2022<br />
Types of <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> Diagnostics<br />
Mammogram<br />
The Mammogram is an X-ray of the breast. It is the best way to find breast cancer in early<br />
stages. The Mammogram could not prevent cancer but it can save lives by finding cancer at<br />
earliest. In most Established nations, the mammogram is incorporated with government breast<br />
cancer screening program while in less Established nations; mammogram is on their way to be<br />
adopted by the government.<br />
MRI <strong>Screening</strong> <strong>Market</strong><br />
In a breast MRI screening Test the method includes magnets and radio waves to take the<br />
pictures of the breast. It is used along with mammogram to screen women who are at high risk<br />
for breast cancer. MRI is not used for women who are at average risk.<br />
Mainly the established nations dominate the breast cancer MRI screening test market as it is a<br />
very expensive procedure. The nations like The United State, France and Germany held<br />
control over half of the market in 2016. The other nations who control the market in MRI<br />
screening test were Italy, The United Kingdom and Canada.<br />
Ultrasound Test<br />
Ultrasound is an imaging test which sends high- frequency sound waves through the breast and<br />
converts it into images on viewing screen. No radiation is involved in it. <strong>Screening</strong> test for<br />
breast cancer is not using Ultrasound on its own either it used to complement other screening<br />
tests. However, the use of ultrasound in screening is associated with high rate of both<br />
positive as well as negative outcomes.<br />
© Renub Research LLP Page 2 of 4
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> is estimated to be more than US$ 20 Billion by 2022<br />
<strong>Breast</strong> <strong>Cancer</strong> Awareness around the World<br />
The <strong>Breast</strong> cancer awareness is very low in lower and middle- income nations. In these<br />
nations, the government has no proper program for breast cancer screening because of lack of<br />
government support. Women are not aware of the breast cancer as a fatal disease in these<br />
nations and they cover their problems due to social and cultural issues. One of the main reasons<br />
for the low detection of breast cancer diseases is because of the limited number of lady doctors<br />
in these nations.<br />
The Report Studies the <strong>Breast</strong> <strong>Cancer</strong> <strong>Market</strong> (Mammogram, MRI <strong>Screening</strong> &<br />
Ultrasound Test) on the basis of: Country<br />
1. United States<br />
2. Canada<br />
3. United Kingdom<br />
4. France<br />
5. Germany<br />
6. Italy<br />
7. Spain<br />
8. Netherlands<br />
9. Norway<br />
10. Switzerland<br />
11. India<br />
12. China<br />
13. Japan<br />
14. Korea<br />
15. Singapore<br />
16. Thailand<br />
17. Malaysia<br />
18. Brazil<br />
19. Australia<br />
20. New Zealand<br />
Table of Contents<br />
1. Executive Summary<br />
2. Worldwide <strong>Screening</strong> Population Analysis<br />
3. Worldwide <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> Analysis<br />
4. Worldwide <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> Population & <strong>Market</strong> Share Analysis<br />
5. Worldwide <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> Share Analysis<br />
6. United Kingdom <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
7. France <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
8. Germany <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
9. Italy <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
10. Spain <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
11. Switzerland <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
12. Norway <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
13. Netherlands <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
14. United States <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
15. Canada <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
16. Japan <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
© Renub Research LLP Page 3 of 4
<strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> is estimated to be more than US$ 20 Billion by 2022<br />
17. Korea <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
18. Singapore <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
19. Malaysia <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
20. India <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
21. China <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
22. Thailand <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
23. Brazil <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
24. Australia <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
25. New Zealand <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> & <strong>Forecast</strong><br />
26. <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> Growth Drivers<br />
27. <strong>Breast</strong> <strong>Cancer</strong> <strong>Screening</strong> <strong>Market</strong> Challenges<br />
Vaccines <strong>Market</strong> Report:<br />
http://www.renub.com/vaccines-12-c.php<br />
Renub Research - North America<br />
Rajat Gupta<br />
225 Kristie Ln, Roswell<br />
Georgia 30076, United States<br />
Renub Research - Asia<br />
Ankit Mishra<br />
C – 86, Sector – 10<br />
Noida 201301, India<br />
Tel: +1-678-302-0700<br />
Email: info@renub.com<br />
www.renub.com<br />
Tel: +91-120-421-9822<br />
Email: info@renub.com<br />
www.renub.com<br />
© Renub Research LLP Page 4 of 4
Change language